Genenta Science, a developer of immuno-oncology and cell-based therapeutics, has strengthened its partnership with AGC Biologics, a global CDMO, by amending their Development and Master Services Agreement. This amendment introduces an exclusive GMP suite at the AGC Biologics Cell and Gene Center of Excellence in Milan, dedicated to the manufacturing of Genenta’s cell therapy product, to help ensure compliance with cGMP standards. This strategic move enhances Genenta’s production capabilities, po...